Diagnostic Performance of MRI for Assessing Tumor Response in HER2 Negative Breast Cancer Receiving Neoadjuvant Chemotherapy Is Associated with Molecular Biomarker Profile

AIMS: This study aimed to evaluate the influence of hormonal receptor and Ki-67 proliferation marker in predicting MRI accuracy of measuring residual tumor size in HER2 negative breast cancer receiving neoadjuvant chemotherapy (NAC). METHODS: Fifty-four women were studied. Patients received AC and/o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kuzucan, Aida, Chen, Jeon-Hor, Bahri, Shadfar, Mehta, Rita S., Carpenter, Philip M., Fu, Peter T., Yu, Hon J., Hsiang, David JB, Lane, Karen T., Butler, John A., Feig, Stephen A., Su, Min-Ying
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3342312/
https://ncbi.nlm.nih.gov/pubmed/22444717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2012.01.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados